Tocqueville Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Tocqueville Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-13,650	Closed	-$164K	–	840
2018 Q2	$164K	Buy	+13,650	New	+$140K	﹤0.01%	793
2018 Q1	–	Sell	-13,700	Closed	-$135K	–	851
2017 Q4	$135K	Sell	13,700 -121,300	-90%	-$1.26M	﹤0.01%	781
2017 Q3	$1.66M	Buy	+135,000	New	+$1.99M	0.02%	470
2016 Q4	–	Sell	-25,000	Closed	-$452K	–	831
2016 Q3	$452K	Sell	25,000 -15,000	-38%	-$241K	0.01%	649
2016 Q2	$574K	Hold	40,000	–	–	0.01%	610
2016 Q1	$478K	Hold	40,000	–	–	0.01%	647
2015 Q4	$532K	Sell	40,000 -25,000	-38%	-$307K	0.01%	650
2015 Q3	$698K	Buy	+65,000	New	+$710K	0.01%	624

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

SGA

Sector Gamma AS Oslo, Norway $461M AUM 33.26% 1-Year Est. Return

Tocqueville Asset Management's LXRX Position: Q3 2018 in Review

Tocqueville Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2018, closing a stake of 13,650 shares — an estimated $164K sold.

Tocqueville Asset Management first reported a position in LXRX in Q3 2015 and held it in 8 quarters. The position peaked at $1.66M in Q3 2017. 119 funds tracked by Wall St. Rank hold LXRX as of Q3 2018.

Tocqueville Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Tocqueville Asset Management sold 13,650 Lexicon Pharmaceuticals shares in Q3 2018, an estimated $164K.
Tocqueville Asset Management first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 8 quarters.
Tocqueville Asset Management's Lexicon Pharmaceuticals position peaked at $1.66M in Q3 2017.
119 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2018.

Based on Tocqueville Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.